ALPHA D3 0.25 MCG Israel - English - Ministry of Health

alpha d3 0.25 mcg

truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 0.25 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

ALPHA D3 1.0 MCG Israel - English - Ministry of Health

alpha d3 1.0 mcg

truemed ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

ALPHA D3 1.0 MCG Israel - English - Ministry of Health

alpha d3 1.0 mcg

teva pharmaceutical industries ltd, israel - alfacalcidol - capsules soft gelatin - alfacalcidol 1 mcg - alfacalcidol - alfacalcidol - - renal bone disease (renal osteodystrophy). - hypoparathyroidism. - hyperparathyroidism (with bone disease) - primary and tertiary. - rickets and osteomalacia. - osteoporosis.

CAPD 2 PERITONEAL DIALYSIS SOLUTION Israel - English - Ministry of Health

capd 2 peritoneal dialysis solution

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 16.5 g/l; lactic acid as sodium 3.925 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.

CAPD 3 PERITONEAL DIALYSIS SOLUTION Israel - English - Ministry of Health

capd 3 peritoneal dialysis solution

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - lactic acid as sodium 3.925 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 46.75 g/l; magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.

CAPD 4 PERITONEAL DIALYSIS SOLUTION Israel - English - Ministry of Health

capd 4 peritoneal dialysis solution

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - calcium chloride 0.2573 g/l; sodium chloride 5.786 g/l; glucose as monohydrate 25 g/l; lactic acid as sodium 3.925 g/l; magnesium chloride 0.1017 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.

SYNTHOMYCINE 3 % Israel - English - Ministry of Health

synthomycine 3 %

teva israel ltd - chloramphenicol - ointment - chloramphenicol 3 % - chloramphenicol - chloramphenicol - antibiotic.

EMILY Israel - English - Ministry of Health

emily

abic marketing ltd, israel - ethinylestradiol; gestodene - coated tablets - gestodene 0.075 mg; ethinylestradiol 0.02 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.

SHELLY Israel - English - Ministry of Health

shelly

abic marketing ltd, israel - ethinylestradiol; gestodene - coated tablets - ethinylestradiol 0.03 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.

LEVO Israel - English - Ministry of Health

levo

unipharm ltd, israel - levofloxacin hemihydrate - tablets - levofloxacin hemihydrate 500 mg - levofloxacin - levofloxacin - in adults with infections of mild to moderate severity for the treatment of the following infections when due to levofloxacin - susceptible micro-organisms: acute sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, complicated urinary tract infections including pyelonephritis, skin and soft tissue infections.